JANSSEN PHARMACEUTICA NV TRADE DATA ANALYSIS
Access comprehensive trade data for Janssen Pharmaceutica Nv with ease. Explore trade shipments, top suppliers & buyers, and values without the hassle.
Janssen Pharmaceutica Nv – Overview
Eximpedia analyzes Janssen Pharmaceutica Nv export and import records, including data from 0 buyers and 1 suppliers. We provide an intelligence report of Janssen Pharmaceutica Nv that covers trade statistics, shipment values, quantities, exporters & importers and trade destinations
Janssen Pharmaceutica Nv Buyers, Suppliers & Shipments
Janssen Pharmaceutica Nv import markets
Explore the Janssen Pharmaceutica Nv import market with monthly import values, major importers, HS Codes, key ports, top suppliers, and competitors
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 3004390000 | 69.54 | 7 | 4.64 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004900000 | 31.80 | 111 | 73.51 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3002909000 | 14.03 | 6 | 3.97 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
| 3006930000 | 7.28 | 5 | 3.31 |
| PHARMACEUTICAL GOODS SPECIFIED IN NOTE 4 TO THIS CHAPTER | |||
| 3002150000 | 2.17 | 20 | 13.25 |
| HUMAN BLOOD; ANIMAL BLOOD PREPARED FOR THERAPEUTIC, PROPHYLACTIC OR DIAGNOSTIC USES; ANTISERA, OTHER BLOOD FRACTIONS AND IMMUNOLOGICAL PRODUCTS, WHETHER OR NOT MODIFIED OR OBTAINED BY MEANS OF BIOTECHNOLOGICAL PROCESSES; VACCINES, TOXINS, CULTURES OF MICR | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| CANADA | 68.98 | 7 | 4.64 |
| SWITZERLAND | 21.69 | 19 | 12.58 |
| UNITED STATES | 17.86 | 41 | 27.15 |
| ITALY | 7.56 | 14 | 9.27 |
| GERMANY | 5.61 | 14 | 9.27 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| UA209140 | 3.63 | 88 | 58.28 |
| UA209230 | 119.87 | 61 | 40.40 |
| UA209170 | 1.12 | 1 | 0.66 |
| UA100290 | 0.19 | 1 | 0.66 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| JV OPTIMA FARM LIMITED | 30.45 | 5786 |
| MERCK PHARMACEUTICAL ECZA AND KIMYA TIC A | 60.34 | 197 |
| ARES TRADING URUGUAY SA | 120.78 | 267 |
| REPRESENTATIVE OFFICE OF JANSSEN PHARMACEUTICALS NV | 139.38 | 37 |
| NOVO NORDISK HEALTH PRODUCTS TRADE LIMITED COMPANY | 234.11 | 2552 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| PFIZER SERVICE COMPANY BV | 22.08 | 2884 |
| ELI LILLY EXPORT S A | 28.30 | 666 |
| ARES TRADING SA | 66.05 | 376 |
| JANSSEN PHARMACEUTICA NV | 139.07 | 4338 |
| NOVO NORDISK | 226.49 | 721 |
If you are looking to establish relationship with Janssen Pharmaceutica Nv Automation you can save time by getting access to the key decision makers and get a detailed report.
Janssen Pharmaceutica Nv Import Shipments
Discover the Janssen Pharmaceutica Nv with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 3002150000 | 1. MODIFIED IMMUNOLOGICAL PRODUCTS. MEDICINAL PRODUCT FOR HUMAN USE, PUT UP FOR RETAIL SALE. SERIES 22K111MD: SIMPONI®, SOLUTION FOR INJECTION 100 MG/ML IN 0.5 ML SOLUTION IN A PRE-FILLED SYRINGE OF TYPE 1 GLASS WITH A RUBBER TIP AND A NEEDLE COVERED WITH A CAP, IN A HANDLE WITH AUTOIN BY AN INJECTOR, 1 PEN IN A CARDBOARD BOX - 3 PACKS. MANUFACTURER: PRODUCTION OF MEDICINAL PRODUCT, PRIMARY PACKAGING: BAXTER PHARMACEUTICAL SOLUTIONS LLC, USA; SECONDARY PACKAGING, SERIES RELEASE, QUALITY CONTROL OF GL: SILAG AG, CH.""" |  |
|
UNITED STATES | UKRAINE | 0 |
| 3002150000 | 1. MEDICINAL PRODUCTS FOR HUMANS, MODIFIED IMMUNOLOGICAL PRODUCTS, PACKAGED FOR RETAIL SALE, NOT IN AN AEROSOL PACKAGE. SIMPONI® SOLUTION FOR INJECTION 100 MG/ML IN 0.5 ML OF SOLUTION IN A PRE-FILLED SYRINGE MADE OF TYPE 1 GLASS WITH A RUBBER TIP AND A NEEDLE COVERED WITH A CAP , IN A PEN WITH AN AUTO-INJECTOR; 1 PEN IN A CARDBOARD BOX/1 ML SOLUTION CONTAINS GOLIMUMAB 100 MG/BAXTER PHARMACEUTICAL SOLUTIONS LLS (PRODUCTION OF MEDICINAL PRODUCT, PRIMARY PACKAGING), USA""" | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, FOR THERAPEUTIC USE, PACKAGED FOR RETAIL SALE (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, ALKALOIDS, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. RISPOLEPT® COATED TABLETS, 2 MG EACH; 10 TABLETS IN A BLISTER; 2 BLISTERS IN A CARDBOARD PACK/1 FILM-COATED TABLET CONTAINING 2 MG OF RISPERIDONE/JANSSEN-SILAG S.P.A., ITALY""" | |
|
ITALY | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL SALE. SERIES 23AQ159: VERMOKS®, 100 MG TABLETS, 6 TABLETS IN A BLISTER; 1 BLISTER IN A CARDBOARD PACK - 8,000 UNITS. SERIES 23JQ045: VERMOKS®, 100 MG TABLETS, 6 TABLETS IN A BLISTER; 1 BLISTER IN A CARDBOARD PACK - 15,400 UNITS (ACTIVE SUBSTANCE - MEBENDAZOLE) MANUFACTURER: LUSOMEDIKAMENTA SOCIEDAD TEKNICA PHARMACEUTIKA, S.A., PT.""" | |
|
PORTUGAL | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL SALE. SERIES MKB3B00: RISPOLEPT®, ORAL SOLUTION, 1 MG/ML, 30 ML IN A BOTTLE; 1 BOTTLE EACH WITH A PIPETTE-DISPENSER IN A CARDBOARD PACKAGE - 600 PACKS. (ACTIVE INGREDIENT - RISPERIDONE) MANUFACTURER: JANSSEN PHARMACEUTIKA N.V., VE.""" | |
|
BELGIUM | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL SALE. SERIES NIL1S00: RISPOLEPT®, FILM-COATED TABLETS, 2 MG, 10 TABLETS IN A BLISTER; 2 BLISTERS IN A CARDBOARD PACK - 320 PACKS. (ACTIVE SUBSTANCE - RISPERIDONE) MANUFACTURER: JANSSEN-SILAG S.P.A., IT.""" | |
|
ITALY | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL TRADE. SERIES NFZSE01: TOPAMAKS®, 25 MG CAPSULES, 28 CAPSULES IN A BOTTLE; 1 VIAL IN A CARDBOARD PACK - 192 UNITS. SERIES NEZT300: TOPAMAKS®, 50 MG CAPSULES, 28 CAPSULES IN A VIAL; 1 VIAL IN A CARDBOARD PACK - 144 UNITS (ACTIVE INGREDIENT - TOPIRAMATE) MANUFACTURER: PRIMARY AND SECONDARY PACKAGING, SERIAL RELEASE PERMIT: JANSSEN-SILAG S.P.A., IT, PRODUCTION OF UNPACKAGED PRODUCT: JANSSEN ORTHO LLS, US. """ | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL SALE. SERIES NCSS700: PARIET®, ENTERIC TABLETS OF 10 MG, 14 TABLETS IN A BLISTER; 1 BLISTER IN A CARDBOARD BOX - 156 UNITS. SERIES NFSS000: PARIET®, 20 MG ENTERIC TABLETS, 14 TABLETS IN A BLISTER; 1 BLISTER IN A CARDBOARD BOX - 468 UNITS (ACTIVE INGREDIENT - RABEPRAZOLE SODIUM) MANUFACTURER: UNPACKAGED PRODUCT PRODUCTION: BUSHU PHARMACEUTICALS LTD., JP, PRIMARY AND SECONDARY PACKAGING, SERIAL RELEASE: SILAG AG, SN.""" | |
|
JAPAN | UKRAINE | 0 |
| 3004900000 | 1. MEDICINES FOR HUMANS, WITHOUT THE FOLLOWING: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, PACKAGED FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: TOPAMAKS ®, CAPSULES OF 25 MG, 28 CAPSULES IN A BOTTLE; 1 VIAL IN A CARDBOARD PACK / 1 CAPSULE CONTAINS TOPIRAMATE 25 MG; MANUFACTURER JANSSEN-SILAG S.P.A. (PRIMARY AND SECONDARY PACKAGING, PERMISSION TO RELEASE SERIES), ITALY/JANSSEN ORTHO LLS (PRODUCTION OF UNPACKAGED PRODUCT), USA; TOPAMAX ®, 50 MG CAPSULES, 28 CAPSULES IN A BOTTLE; 1 VIAL IN A CARDBOARD PACK / 1 CAPSULE CONTAINS TOPIRAMATE 50 MG; MANUFACTURER JANSSEN-SILAG S.P.A. (PRIMARY AND SECONDARY PACKAGING, SERIAL RELEASE APPROVAL), ITALY/JANSSEN ORTHO LLS (PRODUCTION OF BULK PRODUCT), USA;""" | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, PACKAGED FOR RETAIL SALE: SERIES MGSK000: RISPOLEPT KONSTA®, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTIONS OF PROLONGED ACTION OF 37.5 MG; SET CONTAINING: 1 VIAL WITH POWDER, 1 SYRINGE WITH 2 ML OF SOLVENT (CARMELLOSE SODIUM 40 MPA.S; POLYSORBATE 20; SODIUM HYDROGEN PHOSPHATE, DIHYDRATE; ANHYDROUS CITRIC ACID; SODIUM CHLORIDE; SODIUM HYDROXIDE; WATER FOR INJECTIONS), 1 NEEDLELESS DEVICE WEST FOR PREPARATION OF SUSPENSION AND 2 NEEDLES 25 MM AND 51 MM LONG (WITH PROTECTIVE DEVICES) FOR INTRAMUSCULAR INJECTIONS IN A PACK - 20 PACKS. SERIES MFSK000:RISPOLEPT KONSTA®, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTIONS OF PROLONGED ACTION 25 MG EACH; SET CONTAINING: 1 VIAL WITH POWDER, 1 SYRINGE WITH 2 ML OF SOLVENT (CARMELLOSE SODIUM 40 MPA.S; POLYSORBATE 20; SODIUM HYDROGEN PHOSPHATE, DIHYDRATE; ANHYDROUS CITRIC ACID; SODIUM CHLORIDE; SODIUM HYDROXIDE; WATER FOR INJECTIONS), 1 NEEDLELESS DEVICE WEST FOR PREPARING A SUSPENSION AND 2 NEEDLES 25 MM AND 51 MM LONG (WITH PROTECTIVE DEVICES) FOR INTRAMUSCULAR INJECTIONS IN A PACK - 70 PACKS (ACTIVE SUBSTANCE - RISPERIDONE) MANUFACTURER: PRODUCTION AND PRIMARY PACKAGING OF THE SOLVENT: SILAG AG, SN , PRODUCTION AND PRIMARY PACKAGING OF THE POWDER: ALKERMES INC., US, SECONDARY PACKAGING AND RELEASE OF THE SERIES: SILAG AG, SN.""" | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, FOR THERAPEUTIC USE, PACKAGED FOR RETAIL SALE (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, ALKALOIDS, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. RISPOLEPT KONSTA® POWDER AND SOLVENT FOR SUSPENSION FOR INJECTIONS OF PROLONGED ACTION 37.5 MG EACH; SET CONTAINING: 1 VIAL WITH POWDER, 1 SYRINGE WITH 2 ML OF SOLVENT (CARMELLOSE SODIUM 40 MPA.S; POLYSORBATE 20; SODIUM HYDROGEN PHOSPHATE, DIHYDRATE; ANHYDROUS CITRIC ACID; SODIUM CHLORIDE; SODIUM HYDROXIDE; WATER FOR INJECTIONS), 1 NEEDLELESS DEVICE WEST FOR PREPARATION OF SUSPENSION AND 2 NEEDLES 25 MM AND 51 MM LONG (WITH PROTECTIVE DEVICES) FOR INTRAMUSCULAR INJECTIONS IN A PACK /1 VIAL CONTAINS RISPERIDONE 37.5 MG (1 G OF MICROGRANULES CONTAINS 381 MG RISPERIDONE)/SILAG AG ( PRODUCTION AND PRIMARY SOLVENT PACKAGING, SECONDARY PACKAGING AND BATCH RELEASE), SWITZERLAND ALKERMES INC. (PRODUCTION AND PRIMARY PACKAGING OF POWDER), USA""" | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, FOR THERAPEUTIC USE, PACKAGED FOR RETAIL SALE (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, ALKALOIDS, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. PARIET® ENTERIC TABLETS OF 10 MG; 14 TABLETS IN A BLISTER; 1 BLISTER IN A CARDBOARD BOX/1 TABLET CONTAINS 10 MG OF RABEPRAZOLE SODIUM, WHICH CORRESPONDS TO 9.42 MG OF RABEPRAZOLE/BUSHU PHARMACEUTICALS LTD. (PRODUCTION OF UNPACKAGED PRODUCT), JAPAN PARIET® ENTERIC TABLETS OF 20 MG; 14 TABLETS IN A BLISTER; 1 BLISTER IN A CARDBOARD BOX/1 TABLET CONTAINS 20 MG OF RABEPRAZOLE SODIUM, CORRESPONDING TO 18.85 MG OF RABEPRAZOLE/BUSHU PHARMACEUTICALS LTD. (PRODUCTION OF UNPACKAGED PRODUCT), JAPAN""" | |
|
JAPAN | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, FOR THERAPEUTIC USE, PACKAGED FOR RETAIL (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, ALKALOIDS, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. TOPAMAKS® 25 MG CAPSULES; 28 CAPSULES IN A BOTTLE; 1 VIAL IN A CARDBOARD PACK/1 CAPSULE CONTAINS TOPIRAMATE 25 MG/JANSSEN-SILAG S.P.A. (PRIMARY AND SECONDARY PACKAGING, PERMISSION TO RELEASE A SERIES), ITALY JANSSEN ORTO LLS (PRODUCTION OF UNPACKAGED PRODUCT), USATOPAMAX® 50 MG CAPSULES; 28 CAPSULES IN A BOTTLE; 1 VIAL IN A CARDBOARD PACK/1 CAPSULE CONTAINS TOPIRAMATE 50 MG/JANSSEN-SILAG S.P.A. (PRIMARY AND SECONDARY PACKAGING, PERMISSION TO ISSUE A SERIES), ITALY JANSSEN ORTO LLS (PRODUCTION OF UNPACKAGED PRODUCT), USA""" | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, FOR THERAPEUTIC USE, PACKAGED FOR RETAIL SALE (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, ALKALOIDS, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. RISPOLEPT® ORAL SOLUTION, 1 MG/ML IN 30 ML IN A BOTTLE TOGETHER WITH A DOSING PIPETTE IN A CARDBOARD PACKAGE / 1 ML OF SOLUTION CONTAINS 1 MG OF RISPERIDONE / JANSSEN PHARMACEUTIKA NV, BELGIUMXEPLION® SUSPENSION FOR INJECTIONS OF PROLONGED ACTION, 100 MG/ML IN 1.0 ML IN A PRE-FILLED SYRINGE; 1 SYRINGE AND 2 NEEDLES FOR INTRAMUSCULAR INJECTIONS IN A CARDBOARD BOX/1 ML OF SUSPENSION CONTAINS PALIPERIDONE PALMITATE IN AN AMOUNT CORRESPONDING TO 100 MG OF PALIPERIDONE/JANSSEN PHARMACEUTIKA NV, BELGIUM""" | |
|
BELGIUM | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS FOR HUMANS, FOR THERAPEUTIC USE, PACKAGED FOR RETAIL (NOT CONTAINING PENICILLINS, ANTIBIOTICS, HORMONES, ALKALOIDS, VITAMINS, IODINE COMPOUNDS), NOT IN AEROSOL PACKAGING. VERMOX® 100 MG TABLETS; 6 TABLETS IN A BLISTER; 1 BLISTER IN A CARDBOARD PACK/1 TABLET CONTAINS 100 MG OF MEBENDAZOLE/LUSOMEDIKAMENTA SOCIEDADE TECNICA PHARMACEUTIKA, S.A., PORTUGAL""" | |
|
PORTUGAL | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS, FOR USE IN CONDUCTING CLINICAL STUDIES UNDER STUDY CODE 67652000PCR1001:- NIRAPARIB 100 MG (NIRAPARIB) CAPSULES 100 MG (72 CAPSULES) - 6 PCS. SERIES - ABMF-10267 EXPIRY DATE 03/21/2024TRADEMARK: QUOTIENTMANUFACTURER: QUOTIENT SCIENCES - PHILADELPHIA , LCC | |
|
UNITED STATES | UKRAINE | 0 |
| 3004900000 | 1. MEDICINAL PRODUCTS CONTAINING HORMONES OR OTHER PRODUCTS OF PRODUCT HEADING 2937 FOR USE IN CONDUCTING CLINICAL STUDIES UNDER RESEARCH CODE 64264681LYM1002:- JNJ-64264681 CAPSULES 140 MG 24 CAPSULES - 7 PCS. SERIES - T328271 EXPIRATION DATE 06/14/2024TRADEMARK: SHANGHAI STA PHARMACEUTICAL PRODUCTCO .,LTD. MANUFACTURER: SHANGHAI STA PHARMACEUTICAL PRODUCT CO.,LTD.""" | |
|
CHINA | UKRAINE | 0 |
| 3004900000 | 1. MEDICINES FOR CLINICAL MEDICAL RESEARCH ACCORDING TO PROTOCOL AC-055-315: MACITENTAN 10 MG / PLACEBO 36 FILM COATED TABLETS - 380 PACKS. REF/NUMBER: T356372. EXPIRY DATE UNTIL 04/24/2028. STORAGE CONDITIONS: FROM +15 GR.С UP TO +30 GR. S. MANUFACTURER PATHEON FRANCETRADE MARK PATHEON FRANCE COUNTRY OF MANUFACTURE: FR | |
|
FRANCE | UKRAINE | 0 |
| 3004900000 | 1. MEDICINES FOR CLINICAL MEDICAL RESEARCH ACCORDING TO PROTOCOL AC-055-315: MACITENTAN 75 MG / PLACEBO 36 FILM COATED TABLETS - 100 PACKS. REF/NUMBER: T347869. EXPIRY DATE UNTIL 20.06.2025. STORAGE CONDITIONS: FROM +15 GR.С UP TO +30 GR. S. MANUFACTURER EXCELLA GMBH & CO. KGTRADEMARK OF EXCELLA GMBH & CO. KG COUNTRY OF MANUFACTURE: DE | |
|
GERMANY | UKRAINE | 0 |
| 3002150000 | 1. MEDICINAL PRODUCTS FOR HUMANS, MODIFIED IMMUNOLOGICAL PRODUCTS, PACKAGED FOR RETAIL SALE, NOT IN AN AEROSOL PACKAGE. SIMPONI® SOLUTION FOR INJECTION 100 MG/ML IN 0.5 ML OF SOLUTION IN A PRE-FILLED SYRINGE MADE OF TYPE 1 GLASS WITH A RUBBER TIP AND A NEEDLE COVERED WITH A CAP , IN A PEN WITH AN AUTO-INJECTOR; 1 PEN IN A CARDBOARD BOX/1 ML SOLUTION CONTAINS GOLIMUMAB 100 MG/BAXTER PHARMACEUTICAL SOLUTIONS LLS (PRODUCTION OF MEDICINAL PRODUCT, PRIMARY PACKAGING), USA""" | |
|
UNITED STATES | UKRAINE | 0 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Why should you choose Eximpedia?
Broad Range of Country Datasets
Our dedicated team of experts delivers current and flexible data from key global locations, enabling you to make essential decisions with vital information and insights.
Easy to understand deep analysis
We use bespoke layered visualizations for diving deep into our country and logistics data to provide your team with graphical assistance and essential data analysis and reporting.
Most Accurate Information
All of our datasets are quality-controlled by layers of inspection before it ever reach your platform. This helps us maintain the high reliability our clients have come to trust.
Competitive Supplier Engagement Watch
Keep an eye out for any collaboration between your suppliers and your rivals, as this may impact their ability to satisfy your requirements.
Right away on-screen support
With instant remote on-screen assistance, chat support, and user training, our customer success team is available to you around the clock.
Access Database Across 130+ Countries
Explore competitors' shipment histories, statistical and analytical reports, and country-specific information from more than 130 nations.
Janssen Pharmaceutica Nv frequently asked questions
You can explore detailed shipment records of Janssen Pharmaceutica Nv through Eximpedia’s real-time trade insights platform, which provides access to shipment dates, quantities, ports, and product details.
Yes, Eximpedia offers a directory of buyers with similar trade patterns to Janssen Pharmaceutica Nv. Use advanced filters to identify competitors or partners in the same industry.
With our data-driven platform, you can access a curated list of suppliers with comparable product categories and shipment volumes to Janssen Pharmaceutica Nv, helping you expand your sourcing network.
Eximpedia’s trade data highlights Janssen Pharmaceutica Nv’s major exports, along with their trade destinations and origins.
We provide detailed analytics, including trade volumes, market trends, port usage, and competitor insights, to help businesses understand Janssen Pharmaceutica Nv’s trade activities.
Traders can collaborate with Janssen Pharmaceutica Nv by contacting them through their official channels or visiting their headquarters for detailed trade discussions.